The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gut Microbiome Market Research Report 2025
Synopsis
The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market.
The global Gut Microbiome market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gut Microbiome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gut Microbiome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gut Microbiome in Human is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gut Microbiome include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gut Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gut Microbiome.
Report Scope
The Gut Microbiome market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gut Microbiome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gut Microbiome companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Segment by Application
Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gut Microbiome companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market.
The global Gut Microbiome market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gut Microbiome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gut Microbiome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gut Microbiome in Human is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gut Microbiome include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gut Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gut Microbiome.
Report Scope
The Gut Microbiome market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gut Microbiome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gut Microbiome companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Segment by Application
Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gut Microbiome companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gut Microbiome Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Obesity
1.2.3 Inflammatory Bowel Disease (IBD)
1.2.4 Diabetes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gut Microbiome Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Human
1.3.3 Animal
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gut Microbiome Market Perspective (2019-2030)
2.2 Gut Microbiome Growth Trends by Region
2.2.1 Global Gut Microbiome Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gut Microbiome Historic Market Size by Region (2019-2024)
2.2.3 Gut Microbiome Forecasted Market Size by Region (2025-2030)
2.3 Gut Microbiome Market Dynamics
2.3.1 Gut Microbiome Industry Trends
2.3.2 Gut Microbiome Market Drivers
2.3.3 Gut Microbiome Market Challenges
2.3.4 Gut Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gut Microbiome Players by Revenue
3.1.1 Global Top Gut Microbiome Players by Revenue (2019-2024)
3.1.2 Global Gut Microbiome Revenue Market Share by Players (2019-2024)
3.2 Global Gut Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gut Microbiome Revenue
3.4 Global Gut Microbiome Market Concentration Ratio
3.4.1 Global Gut Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gut Microbiome Revenue in 2023
3.5 Gut Microbiome Key Players Head office and Area Served
3.6 Key Players Gut Microbiome Product Solution and Service
3.7 Date of Enter into Gut Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gut Microbiome Breakdown Data by Type
4.1 Global Gut Microbiome Historic Market Size by Type (2019-2024)
4.2 Global Gut Microbiome Forecasted Market Size by Type (2025-2030)
5 Gut Microbiome Breakdown Data by Application
5.1 Global Gut Microbiome Historic Market Size by Application (2019-2024)
5.2 Global Gut Microbiome Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gut Microbiome Market Size (2019-2030)
6.2 North America Gut Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gut Microbiome Market Size by Country (2019-2024)
6.4 North America Gut Microbiome Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gut Microbiome Market Size (2019-2030)
7.2 Europe Gut Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gut Microbiome Market Size by Country (2019-2024)
7.4 Europe Gut Microbiome Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gut Microbiome Market Size (2019-2030)
8.2 Asia-Pacific Gut Microbiome Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gut Microbiome Market Size by Region (2019-2024)
8.4 Asia-Pacific Gut Microbiome Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gut Microbiome Market Size (2019-2030)
9.2 Latin America Gut Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gut Microbiome Market Size by Country (2019-2024)
9.4 Latin America Gut Microbiome Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gut Microbiome Market Size (2019-2030)
10.2 Middle East & Africa Gut Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gut Microbiome Market Size by Country (2019-2024)
10.4 Middle East & Africa Gut Microbiome Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viome
11.1.1 Viome Company Detail
11.1.2 Viome Business Overview
11.1.3 Viome Gut Microbiome Introduction
11.1.4 Viome Revenue in Gut Microbiome Business (2019-2024)
11.1.5 Viome Recent Development
11.2 Carbiotix
11.2.1 Carbiotix Company Detail
11.2.2 Carbiotix Business Overview
11.2.3 Carbiotix Gut Microbiome Introduction
11.2.4 Carbiotix Revenue in Gut Microbiome Business (2019-2024)
11.2.5 Carbiotix Recent Development
11.3 Ixcela, Inc
11.3.1 Ixcela, Inc Company Detail
11.3.2 Ixcela, Inc Business Overview
11.3.3 Ixcela, Inc Gut Microbiome Introduction
11.3.4 Ixcela, Inc Revenue in Gut Microbiome Business (2019-2024)
11.3.5 Ixcela, Inc Recent Development
11.4 Novome Biotechnologies
11.4.1 Novome Biotechnologies Company Detail
11.4.2 Novome Biotechnologies Business Overview
11.4.3 Novome Biotechnologies Gut Microbiome Introduction
11.4.4 Novome Biotechnologies Revenue in Gut Microbiome Business (2019-2024)
11.4.5 Novome Biotechnologies Recent Development
11.5 Kintai Therapeutics
11.5.1 Kintai Therapeutics Company Detail
11.5.2 Kintai Therapeutics Business Overview
11.5.3 Kintai Therapeutics Gut Microbiome Introduction
11.5.4 Kintai Therapeutics Revenue in Gut Microbiome Business (2019-2024)
11.5.5 Kintai Therapeutics Recent Development
11.6 ProDigest
11.6.1 ProDigest Company Detail
11.6.2 ProDigest Business Overview
11.6.3 ProDigest Gut Microbiome Introduction
11.6.4 ProDigest Revenue in Gut Microbiome Business (2019-2024)
11.6.5 ProDigest Recent Development
11.7 Caelus Health
11.7.1 Caelus Health Company Detail
11.7.2 Caelus Health Business Overview
11.7.3 Caelus Health Gut Microbiome Introduction
11.7.4 Caelus Health Revenue in Gut Microbiome Business (2019-2024)
11.7.5 Caelus Health Recent Development
11.8 LNC Therapeutics
11.8.1 LNC Therapeutics Company Detail
11.8.2 LNC Therapeutics Business Overview
11.8.3 LNC Therapeutics Gut Microbiome Introduction
11.8.4 LNC Therapeutics Revenue in Gut Microbiome Business (2019-2024)
11.8.5 LNC Therapeutics Recent Development
11.9 AnimalBiome
11.9.1 AnimalBiome Company Detail
11.9.2 AnimalBiome Business Overview
11.9.3 AnimalBiome Gut Microbiome Introduction
11.9.4 AnimalBiome Revenue in Gut Microbiome Business (2019-2024)
11.9.5 AnimalBiome Recent Development
11.10 Assembly Biosciences
11.10.1 Assembly Biosciences Company Detail
11.10.2 Assembly Biosciences Business Overview
11.10.3 Assembly Biosciences Gut Microbiome Introduction
11.10.4 Assembly Biosciences Revenue in Gut Microbiome Business (2019-2024)
11.10.5 Assembly Biosciences Recent Development
11.11 Enterome BioScience
11.11.1 Enterome BioScience Company Detail
11.11.2 Enterome BioScience Business Overview
11.11.3 Enterome BioScience Gut Microbiome Introduction
11.11.4 Enterome BioScience Revenue in Gut Microbiome Business (2019-2024)
11.11.5 Enterome BioScience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gut Microbiome Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Obesity
Table 3. Key Players of Inflammatory Bowel Disease (IBD)
Table 4. Key Players of Diabetes
Table 5. Key Players of Others
Table 6. Global Gut Microbiome Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Gut Microbiome Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Gut Microbiome Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Gut Microbiome Market Share by Region (2019-2024)
Table 10. Global Gut Microbiome Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Gut Microbiome Market Share by Region (2025-2030)
Table 12. Gut Microbiome Market Trends
Table 13. Gut Microbiome Market Drivers
Table 14. Gut Microbiome Market Challenges
Table 15. Gut Microbiome Market Restraints
Table 16. Global Gut Microbiome Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Gut Microbiome Market Share by Players (2019-2024)
Table 18. Global Top Gut Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiome as of 2023)
Table 19. Ranking of Global Top Gut Microbiome Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Gut Microbiome Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gut Microbiome Product Solution and Service
Table 23. Date of Enter into Gut Microbiome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gut Microbiome Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Gut Microbiome Revenue Market Share by Type (2019-2024)
Table 27. Global Gut Microbiome Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Gut Microbiome Revenue Market Share by Type (2025-2030)
Table 29. Global Gut Microbiome Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Gut Microbiome Revenue Market Share by Application (2019-2024)
Table 31. Global Gut Microbiome Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Gut Microbiome Revenue Market Share by Application (2025-2030)
Table 33. North America Gut Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Gut Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Gut Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Gut Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Gut Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Gut Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Gut Microbiome Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Gut Microbiome Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Gut Microbiome Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Gut Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Gut Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gut Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gut Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Gut Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Gut Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 48. Viome Company Detail
Table 49. Viome Business Overview
Table 50. Viome Gut Microbiome Product
Table 51. Viome Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 52. Viome Recent Development
Table 53. Carbiotix Company Detail
Table 54. Carbiotix Business Overview
Table 55. Carbiotix Gut Microbiome Product
Table 56. Carbiotix Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 57. Carbiotix Recent Development
Table 58. Ixcela, Inc Company Detail
Table 59. Ixcela, Inc Business Overview
Table 60. Ixcela, Inc Gut Microbiome Product
Table 61. Ixcela, Inc Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 62. Ixcela, Inc Recent Development
Table 63. Novome Biotechnologies Company Detail
Table 64. Novome Biotechnologies Business Overview
Table 65. Novome Biotechnologies Gut Microbiome Product
Table 66. Novome Biotechnologies Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 67. Novome Biotechnologies Recent Development
Table 68. Kintai Therapeutics Company Detail
Table 69. Kintai Therapeutics Business Overview
Table 70. Kintai Therapeutics Gut Microbiome Product
Table 71. Kintai Therapeutics Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 72. Kintai Therapeutics Recent Development
Table 73. ProDigest Company Detail
Table 74. ProDigest Business Overview
Table 75. ProDigest Gut Microbiome Product
Table 76. ProDigest Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 77. ProDigest Recent Development
Table 78. Caelus Health Company Detail
Table 79. Caelus Health Business Overview
Table 80. Caelus Health Gut Microbiome Product
Table 81. Caelus Health Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 82. Caelus Health Recent Development
Table 83. LNC Therapeutics Company Detail
Table 84. LNC Therapeutics Business Overview
Table 85. LNC Therapeutics Gut Microbiome Product
Table 86. LNC Therapeutics Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 87. LNC Therapeutics Recent Development
Table 88. AnimalBiome Company Detail
Table 89. AnimalBiome Business Overview
Table 90. AnimalBiome Gut Microbiome Product
Table 91. AnimalBiome Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 92. AnimalBiome Recent Development
Table 93. Assembly Biosciences Company Detail
Table 94. Assembly Biosciences Business Overview
Table 95. Assembly Biosciences Gut Microbiome Product
Table 96. Assembly Biosciences Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 97. Assembly Biosciences Recent Development
Table 98. Enterome BioScience Company Detail
Table 99. Enterome BioScience Business Overview
Table 100. Enterome BioScience Gut Microbiome Product
Table 101. Enterome BioScience Revenue in Gut Microbiome Business (2019-2024) & (US$ Million)
Table 102. Enterome BioScience Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gut Microbiome Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gut Microbiome Market Share by Type: 2023 VS 2030
Figure 3. Obesity Features
Figure 4. Inflammatory Bowel Disease (IBD) Features
Figure 5. Diabetes Features
Figure 6. Others Features
Figure 7. Global Gut Microbiome Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Gut Microbiome Market Share by Application: 2023 VS 2030
Figure 9. Human Case Studies
Figure 10. Animal Case Studies
Figure 11. Gut Microbiome Report Years Considered
Figure 12. Global Gut Microbiome Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Gut Microbiome Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Gut Microbiome Market Share by Region: 2023 VS 2030
Figure 15. Global Gut Microbiome Market Share by Players in 2023
Figure 16. Global Top Gut Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiome as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Gut Microbiome Revenue in 2023
Figure 18. North America Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Gut Microbiome Market Share by Country (2019-2030)
Figure 20. United States Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Gut Microbiome Market Share by Country (2019-2030)
Figure 24. Germany Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Gut Microbiome Market Share by Region (2019-2030)
Figure 32. China Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Gut Microbiome Market Share by Country (2019-2030)
Figure 40. Mexico Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Gut Microbiome Market Share by Country (2019-2030)
Figure 44. Turkey Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Gut Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Viome Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 47. Carbiotix Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 48. Ixcela, Inc Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 49. Novome Biotechnologies Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 50. Kintai Therapeutics Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 51. ProDigest Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 52. Caelus Health Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 53. LNC Therapeutics Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 54. AnimalBiome Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 55. Assembly Biosciences Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 56. Enterome BioScience Revenue Growth Rate in Gut Microbiome Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
